Compound Detail
CHEMBL6000292
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc(N[C@H](C)c2cccc(C(F)(F)CO)c2F)c2cn(C34CCC(CC3)C4)c(=O)cc2n1
Basic Information
| ChEMBL ID | CHEMBL6000292 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HEYHLAZVGYNRDI-OUCSSDNDSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
472.5
MW (Da)
4.79
ALogP
6
HBA
2
HBD
80.0
PSA (Ų)
0.54
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SOS1-KRAS CHEMBL5465393 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SOS1-KRAS | IC50 | = | 1.0 | nM | 9.0 | TBDAlphaScreen Binding Assay: Compounds are diluted to a final start concentrati... | - |
Data from ChEMBL 36 via Core Engine